March Altus Capital Management

March Altus Capital Management as of Sept. 30, 2014

Portfolio Holdings for March Altus Capital Management

March Altus Capital Management holds 24 positions in its portfolio as reported in the September 2014 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
United Therapeutics Corporation (UTHR) 8.7 $22M 170k 128.65
Mallinckrodt Pub SHS 7.0 $18M 196k 90.15
Dex (DXCM) 6.1 $15M 385k 39.99
Aegerion Pharmaceuticals 5.4 $14M 403k 33.38
Universal American 5.2 $13M 1.6M 8.04
Eli Lilly & Co. (LLY) 5.2 $13M 201k 64.85
Johnson & Johnson (JNJ) 5.2 $13M 122k 106.59
Healthsouth Corp Com New 5.2 $13M 353k 36.90
Zeltiq Aesthetics 4.8 $12M 538k 22.63
Alexion Pharmaceuticals 4.4 $11M 67k 165.82
Biogen Idec (BIIB) 4.3 $11M 33k 330.81
AMAG Pharmaceuticals 4.3 $11M 339k 31.91
Zoetis Cl A (ZTS) 4.3 $11M 291k 36.95
Acorda Therapeutics 4.1 $10M 304k 33.88
Hca Holdings (HCA) 4.1 $10M 145k 70.52
Perrigo SHS (PRGO) 4.0 $10M 67k 150.20
AmerisourceBergen (COR) 3.9 $9.9M 128k 77.30
Universal Hlth Svcs CL B (UHS) 3.9 $9.7M 93k 104.50
Select Medical Holdings Corporation (SEM) 3.3 $8.4M 698k 12.03
West Pharmaceutical Services (WST) 2.5 $6.2M 139k 44.76
Enzymotec SHS 1.8 $4.6M 682k 6.68
ResMed (RMD) 1.7 $4.3M 87k 49.27
Momenta Pharmaceuticals 0.5 $1.2M 104k 11.34
Luminex Corporation 0.1 $195k 10k 19.50